Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. [electronic resource]
Producer: 20070412Description: 526-32 p. digitalISSN:- 1068-9265
- Aged
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Drug Resistance, Neoplasm -- genetics
- Female
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Mutation
- Neoadjuvant Therapy
- Piperazines -- administration & dosage
- Proto-Oncogene Proteins c-kit -- genetics
- Pyrimidines -- administration & dosage
- Stomach Neoplasms -- drug therapy
- Time Factors
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.